PRLHR and Alzheimer disease: Since the methylation of CpG islands located in promoter regions traditionally leads to the silencing of gene expression, we hypothesize that the increased PRLHR methylation levels found in AD patients may induce the downregulation of the PRLHR receptor expression in the hippocampus of AD patients.